← Open Payments lookup

MARICELLE GAMAD: Open Payments

NPI 1619344348 · MODESTO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$783 in 33 payments from 13 companies in 2025. Trend: 2023 $770 · 2024 $704 · 2025 $783

Food & beverage: $783
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.7$177
Janssen Pharmaceuticals, Inc4$94
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$80
Vanda Pharmaceuticals Inc.3$80
Alkermes, Inc.3$59
Otsuka America Pharmaceutical, Inc.2$47
Neurocrine BioSciences, Inc.2$47
ACADIA Pharmaceuticals Inc2$45
Merck Sharp & Dohme LLC2$42
Lilly USA, LLC2$39

Products named: UZEDY, CAPLYTA, FANAPT, ARISTADA, INVEGA SUSTENNA, REXULTI, INGREZZA, NUPLAZID.

Industry payments across CA — which companies pay providers there.